HEALTHCARE
-
Harris seeks to lower drug costs for Virginians, building on recent progress
Harris wants to expand the $35 monthly cap on insulin costs and a $2,000 annual cap on out-of-pocket drug costs so that they apply to all Americans, not just seniors on Medicare.
-
Republican dodges questions over abortion rights in key Virginia race
As Donald Trump ties himself into knots to appear more moderate on reproductive rights after years of bragging about his role in overturning the constitutional right to an abortion, a down-ballot Republican in Virginia is following suit.
-
How Republicans blocking the latest IVF bill is playing out in Virginia’s US Senate race
The popularity of in vitro fertilization is being ignored by Republicans fighting to restrict basic reproductive rights.
-
Abortion ban ‘nearly cost me my life,’ Virginians hear from Harris reproductive freedom tour
The Harris-Walz campaign wants voters to understand that the Democratic ticket will fight to restore abortion rights, while Donald Trump and JD Vance have a record of supporting less reproductive freedom.
-
Trump admitted he still has no health care plan. What that means for Virginia
Repeal of the Affordable Care Act would kick 647,768 Virginia residents off of insurance plans and limit the health insurance coverage for hundreds of thousands more.
-
Everything you need to know about the new flu and COVID vaccines
When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here’s what you need to know.
-
Coastal Virginia congressional candidates present stark contrast on abortion rights
Republican US Rep. Jen Kiggans has pushed to restrict access to abortion care, while her Democratic challenger Missy Cotter Smasal wants to defend reproductive freedom.
-
Harris to keep up fight on prescription drug costs that have already helped Virginians
The Biden-Harris administration continues fighting for bills that protect health care access and benefits for Virginians.
-
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
-
Life-saving insulin is cheaper for tens of thousands of Virginians thanks to Biden-Harris price cap
Virginia seniors are saving money on prescription costs thanks to Biden-Harris price slashes.
























